ProfileGDS4718 / 1569974_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 58% 50% 64% 58% 61% 60% 63% 57% 58% 55% 54% 57% 64% 61% 62% 58% 59% 62% 62% 62% 57% 58% 59% 67% 55% 62% 59% 68% 59% 65% 66% 61% 58% 54% 64% 63% 64% 59% 56% 61% 61% 63% 62% 67% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.9802458
GSM549102patient 115, normal, homogenized [OPG study]5.55150
GSM549104patient 119, normal, homogenized [OPG study]6.4128664
GSM549108patient 138, normal, homogenized [OPG study]6.0013858
GSM549119patient 077, normal, homogenized [OPG study]6.1576861
GSM549133patient 032, cancer, homogenized [OPG study]6.0940460
GSM549139patient 042, cancer, homogenized [OPG study]6.3372963
GSM549099patient 107, normal, homogenized [OPG study]5.9210357
GSM549109patient 139, normal, homogenized [OPG study]5.9955658
GSM549110patient 046, normal, homogenized [OPG study]5.7923555
GSM549114patient 063, normal, homogenized [OPG study]5.714854
GSM549122patient 082, normal, homogenized [OPG study]5.9354457
GSM549134patient 033, cancer, homogenized [OPG study]6.3716664
GSM549136patient 036, cancer, homogenized [OPG study]6.2000861
GSM549140patient 044, cancer, homogenized [OPG study]6.2378262
GSM549111patient 047, normal, homogenized [OPG study]6.0200458
GSM549113patient 057, normal, homogenized [OPG study]6.0011159
GSM549132patient 031, cancer, homogenized [OPG study]6.2352862
GSM549137patient 038, cancer, homogenized [OPG study]6.3000562
GSM549142patient 047, cancer, homogenized [OPG study]6.3108162
GSM549100patient 110, normal, homogenized [OPG study]5.9407557
GSM549107patient 135, normal, homogenized [OPG study]5.9495558
GSM549115patient 068, normal, homogenized [OPG study]6.0144659
GSM549116patient 072, normal, homogenized [OPG study]6.6087367
GSM549120patient 078, normal, homogenized [OPG study]5.8020555
GSM549131patient 030, cancer, homogenized [OPG study]6.2670962
GSM549118patient 074, normal, homogenized [OPG study]6.0411959
GSM549129patient 027, cancer, homogenized [OPG study]6.8047268
GSM549123patient 088, normal, homogenized [OPG study]6.0461159
GSM549124patient 006, cancer, homogenized [OPG study]6.4758665
GSM549126patient 015, cancer, homogenized [OPG study]6.569166
GSM549128patient 025, cancer, homogenized [OPG study]6.2144461
GSM549103patient 117, normal, homogenized [OPG study]6.0017558
GSM549117patient 073, normal, homogenized [OPG study]5.6994554
GSM549138patient 041, cancer, homogenized [OPG study]6.3910664
GSM549141patient 045, cancer, homogenized [OPG study]6.3513763
GSM549130patient 028, cancer, homogenized [OPG study]6.3944864
GSM549101patient 111, normal, homogenized [OPG study]6.0675259
GSM549105patient 128, normal, homogenized [OPG study]5.8963156
GSM549106patient 134, normal, homogenized [OPG study]6.2068161
GSM549112patient 048, normal, homogenized [OPG study]6.205761
GSM549125patient 011, cancer, homogenized [OPG study]6.2972463
GSM549127patient 024, cancer, homogenized [OPG study]6.3198962
GSM549135patient 035, cancer, homogenized [OPG study]6.628167